Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. V. Strigunkova"'
Autor:
I. N. Sychev, O. V. Ignatenko, S. V. Yakovlev, L. V. Fedina, E. N. Burmistrova, M. P. Suvorova, T. D. Rastvorova, E. V. Strigunkova, R. Kh. Mukhamadiev
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 21, Iss 1, Pp 24-34 (2024)
The objective was to study the risk factors, outcomes of infections caused by colistin-resistant K. pneumonia (CRKP) and to evaluate the sensitivity of these microorganisms to antibacterial agents to determine the most adequate antibiotic therapy opt
Externí odkaz:
https://doaj.org/article/29b1313ed1f545109536c7393ba3024f
Autor:
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 6, Pp 624-629 (2023)
Aim. To investigate the effect of ABCB1 gene carriage and interdrug interactions on apixaban pharmacokinetics and clinical outcomes in patients with atrial fibrillation and deep vein thrombosis.Material and methods. Patients hospitalized at Yudin Sta
Externí odkaz:
https://doaj.org/article/547d7b56152449b99e64946f0dcd6d76
Autor:
I. N. Sychev, L. V. Fedina, D. A. Gabrielyan, T. D. Rastvorova, E. V. Strigunkova, K. B. Mirzayev, D. A. Sychev
Publikováno v:
Meditsinskiy sovet = Medical Council. :52-64
Cardiovascular disease is the most common cause of death in the world. For almost 60 years vitamin K antagonists (VKAs) have been the mainstay of anticoagulant therapy, but in recent years direct oral anticoagulants (DAACs) have become the anticoagul